Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer's disease pathology

Herline-Killian, K., Pauers, M. M., Lipponen, J. E., Zrzavy, M. A., Gouveia Roque, C., McCurdy, E. P., Chung, K. M., & Hengst, U. (2025). Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer’s disease pathology. Cell Death & Disease, 16(1). https://doi.org/10.1038/s41419-025-07586-0
Authors:
Krystal Herline-Killian
Michael A. Zrzavy
Claudio Gouveia Roque
Kyung Min Chung
Ulrich Hengst
Michaela M. Pauers
Jessica E. Lipponen
Ethan P. McCurdy
Affiliated Authors:
Krystal Herline-Killian
Michael A. Zrzavy
Claudio Gouveia Roque
Kyung Min Chung
Ulrich Hengst
Michaela M. Pauers
Jessica E. Lipponen
Ethan P. McCurdy
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1038/s41419-025-07586-0
PMID:
40164587
DOI:
10.1038/s41419-025-07586-0
Journal:
Cell Death and Disease
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: